ANIXA BIOSCIENCES, INC. Litigation Settlement, Amount (Deprecated 2017-01-31)
ANIXA BIOSCIENCES, INC. (ANIX) had Litigation Settlement, Amount (Deprecated 2017-01-31) of $9.00 million as of 2014-12-29, per its 10-Q filed 2016-08-19.
Discontinued › Notes
us-gaap:LitigationSettlementAmount · last filed 2016-08-19
- 2014-12-29: Litigation Settlement, Amount (Deprecated 2017-01-31) $9.00M.
| Period end | Litigation Settlement, Amount (Deprecated 2017-01-31) |
|---|---|
| 2014-12-29 | $9.00M 10-Q · filed 2016-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |